Wall Street Zen Upgrades Nutex Health (NASDAQ:NUTX) to Buy

Nutex Health (NASDAQ:NUTX – Get Free Report) was upgraded by equities research analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a research report issued on Saturday, Wall Street Zen reports.

Several other equities analysts also recently commented on NUTX. Weiss Ratings upgraded shares of Nutex Health from a “hold (c)” rating to a “hold (c+)” rating in a research note on Tuesday, July 28th. Lake Street Capital reiterated a “buy” rating and issued a $310.00 target price (up from $235.00) on shares of Nutex Health in a report on Tuesday, August 11th. B. Riley Financial reissued a “buy” rating on shares of Nutex Health in a research note on Friday, September 4th. Finally, Zacks Research upgraded Nutex Health from a “hold” rating to a “strong-buy” rating in a report on Monday, August 24th. One analyst has rated the stock with a Strong Buy rating, two have given a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat, Nutex Health currently has a consensus rating of “Buy” and an average price target of $317.50.

Read Our Latest Research Report on NUTX

Nutex Health Price Performance

Shares of NUTX opened at $216.50 on Friday. Nutex Health has a 52-week low of $83.99 and a 52-week high of $224.28. The company has a quick ratio of 4.96, a current ratio of 5.00 and a debt-to-equity ratio of 0.59. The stock has a fifty day simple moving average of $188.64 and a two-hundred day simple moving average of $151.91. The company has a market capitalization of $1.48 billion, a PE ratio of 8.50 and a beta of 0.55.

Nutex Health (NASDAQ:NUTX – Get Free Report) last posted its earnings results on Thursday, August 6th. The company reported $9.38 EPS for the quarter, beating analysts’ consensus estimates of $4.95 by $4.43. The company had revenue of $210.75 million for the quarter, compared to the consensus estimate of $215.03 million. Nutex Health had a return on equity of 39.74% and a net margin of 21.25%. As a group, equities analysts forecast that Nutex Health will post 27.58 EPS for the current year.

Insiders Place Their Bets

In other Nutex Health news, Director Scott Saunders sold 203 shares of the stock in a transaction that occurred on Friday, September 18th. The stock was sold at an average price of $214.25, for a total transaction of $43,492.75. Following the completion of the sale, the director directly owned 400 shares of the company’s stock, valued at approximately $85,700. This trade represents a 33.67% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 44.68% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in the company. BlackRock Inc. purchased a new position in Nutex Health in the 2nd quarter valued at approximately $69,612,000. Winmill & CO. Inc. purchased a new stake in Nutex Health during the second quarter worth $11,168,000. Empowered Funds LLC acquired a new stake in Nutex Health in the second quarter valued at $7,720,000. Pacer Advisors Inc. grew its holdings in Nutex Health by 4.3% in the fourth quarter. Pacer Advisors Inc. now owns 33,289 shares of the company’s stock valued at $5,480,000 after purchasing an additional 1,359 shares during the last quarter. Finally, Bank of New York Mellon Corp purchased a new position in shares of Nutex Health in the second quarter valued at $3,956,000. 5.32% of the stock is owned by hedge funds and other institutional investors.

About Nutex Health

(Get Free Report)

Nutex Health Inc is a physician-led healthcare company that operates an integrated network of micro hospitals, specialty hospitals and other healthcare facilities. Its care-delivery business provides emergency, inpatient and outpatient services designed to offer localized access to hospital care, particularly in communities that may be underserved by traditional hospital systems.

The company also operates a population health management business. Through affiliated physician networks and independent physician associations, Nutex Health provides services such as care coordination, utilization management and support for value-based care arrangements.

Recommended Stories

Receive News & Ratings for Nutex Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutex Health and related companies with MarketBeat.com's FREE daily email newsletter.